Fiedler M, Baumann L, Eichberger J, Gottsauner M, et al. A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck 2026 May 10. doi: 10.1002/hed.70313.
PMID: 42108192